Family Medicine Doctors in Newport, PA Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Michael Andrew Thieblemont, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151    Fax: 717-567-7571

Dr. Madhu Menon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Bretz Ct Ste 100, Newport, PA 17074 Phone: 717-567-3174    Fax: 717-703-0018

Michelle Liane Brenizer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151    Fax: 717-567-7571

Dr. Kendra M Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Bretz Ct Ste 100, Newport, PA 17074 Phone: 717-567-3174    Fax: 717-703-0018

Albert Bauer Knouse Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Red Hill Ct, Newport, PA 17074 Phone: 717-567-3151    Fax: 717-567-7571

News Archive

Russian researchers propose new approach for prevention of thrombosis

A new approach for the prevention of thrombosis was proposed by researchers from the Moscow Institute of Physics and Technology and the Russian National Research Center for Hematology.

Vestagen Technical Textiles introduces Nanotechnology-Based Healthcare Specialty Textiles

Vestagen Technical Textiles today announced its entry into the advanced performance textile arena with the introduction of the first of a new class of Nanotechnology-Based Healthcare Specialty Textiles.

Symphogen initiates Sym004 Phase 2 trial in squamous cell carcinoma of head and neck cancer

Symphogen A/S today announced the initiation of a Phase 2 clinical trial to investigate the safety and efficacy of Sym004 in patients who have failed anti-EGFR monoclonal antibody (mAb)-based therapy, with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

CTI granted additional 180 days to regain compliance with NASDAQ minimum bid price rule

Cell Therapeutics, Inc. today announced that The NASDAQ Stock Market has granted CTI an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5550(a)(2)). Previously, on May 3, 2010, CTI was notified by NASDAQ that CTI did not meet the minimum bid price rule required for continued listing and was provided until November 1, 2010 to achieve compliance.

NICE releases new guidelines to improve cancer care

The National Institute for Health and Clinical Excellence (NICE) has published a new guideline which should help to improve care for thousands of patients with advanced cancer that has spread from an unknown primary location.

Read more Medical News

› Verified 3 days ago